Pancreatic Cancer

Chapter 089. Pancreatic Cancer (Part 4)

5 p | 57 | 4

Effects of insulin on human pancreatic cancer progression modeled in vitro

12 p | 5 | 0

Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro

12 p | 6 | 0

Upregulation of Wnt5a promotes epithelial-tomesenchymal transition and metastasis of pancreatic cancer cells

11 p | 3 | 0

Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model

14 p | 5 | 0

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

10 p | 3 | 0

Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach

9 p | 2 | 0

Circulating tumor cells and circulating tumor DNA provide new insights into pancreatic cancer

12 p | 5 | 0

Dimethylaminoparthenolide and gemcitabine: A survival study using a genetically engineered mouse model of pancreatic cancer

13 p | 11 | 0